FDA Drug recall D-0121-2018
LaBri's Body Health Atomic 60 Capsules Exclusively distributed worldwide by LaBri's Body Health
- FDA Drug
- Class I
- terminated
- Published 2017-12-27
On 2017-12-27 the FDA classified a Class I recall of LaBri's Body Health Atomic 60 Capsules Exclusively distributed worldwide by LaBri's Body Health by Ezweightlosstx, citing marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0121-2018 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2017-07-24 |
| Published | 2017-12-27 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Ezweightlosstx |
| Distribution | US |
Product
LaBri's Body Health Atomic 60 Capsules Exclusively distributed worldwide by LaBri's Body Health.
Reason
Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.
Identifiers
| code_info | All lots remaining within expiry. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0121-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.